Table 3.
VEGF-A | VEGF-C | VEGF-D | PlGF | ||
---|---|---|---|---|---|
(pg/ml) | (pg/ml) | (pg/ml) | (pg/ml) | ||
TC: | |||||
Normal TC group | 22.45 (17.09–32.30) | 77.16 (43.40–125.32) | 201.47 (122.13–335.91) | 2.14 (0.99–3.10) | |
Abnormal TC group | 27.64 (19.86–37.45) | 122.65 (61.12–219.99) | 266.55 (142.79–427.94) | 2.84 (1.78–3.66) | |
z | −2.66b | −3.31b | −2.11b | −2.87b | |
P-value | 0.008* | 0.001* | 0.035* | 0.004* | |
LDL-C: | |||||
Normal LDL-C group | 22.77 (17.41–32.30) | 78.50 (42.61–128.59) | 196.32 (102.48–335.91) | 2.14 (1.00–3.13) | |
Abnormal LDL-C group | 27.64 (19.33–37.06) | 118.52 (55.69–212.44) | 266.55 (178.27–433.74) | 2.84 (1.69–3.66) | |
z | −2.14b | −2.77b | −2.36b | −2.74b | |
P-value | 0.032* | 0.006* | 0.018* | 0.006* | |
TG: | |||||
Normal TG group | 24.85 (18.59–34.20) | 82.65 (46.90–140.71) | 245.08 (128.21–395.90) | 2.47 (1.34–3.28) | |
Abnormal TG group | 24.49 (16.68–32.01) | 115.51 (48.03–207.07) | 209.77 (121.46–361.79) | 1.85 (1.31–3.51) | |
z | −0.84b | −1.48b | −0.51b | −0.74b | |
P-value | 0.400 | 0.140 | 0.610 | 0.458 | |
HDL-C: | |||||
Normal HDL-C group | 24.85 (17.76–33.56) | 99.82 (47.23–186.00) | 227.54 (110.30–405.02) | 2.41 ± 1.34 | |
Abnormal HDL-C group | 24.86 (18.06–33.30) | 81.95 (46.60–117.01) | 233.87 (136.74–363.15) | 2.33 ± 1.17 | |
t/z | −0.29b | −0.99b | −0.10b | −0.37a | |
P-value | 0.772 | 0.321 | 0.921 | 0.712 |
VEGF, vascular endothelial growth; PlGF, placental growth factor; TC, cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol.
Statistically significant: P ≤ 0.05. According to the type of data and the data distribution,
independent-sample t-test, and
Mann-Whitney U-test were applied.